ARCHIVES

RFAs: Patient Outcomes “5-A-Day” Program

This article is from The Cancer Letter archive.

Vol. 18 No. 15 | April 10, 1992

Download PDF Visit The Full Archive

Related Articles

Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin

July 23, 2010

Also STAR trial can be completed with fewer women than planned, NSABP says.

November 7, 2003

BMS, Exelixis To Collaborate On Drug Development.

July 27, 2001

Kerrie Wilson Succeeds Alan Davis As ACS Chief Lobbyist

November 26, 1993

NCI Advisors Criticize Plan To Fund R01s On ESA Research With Amgen, J&J Money.

June 27, 2008

Obituary: Emmanuel Farber, Experimental Pathologist, Dies at Age 95

August 8, 2014